Cart
sales@molnova.com
Inh2-B1
CAS No. 690216-38-7
Inh2-B1 ( STK1 inhibitor B1 )
Catalog No. M15641 CAS No. 690216-38-7
Inh2-B1 (STK1 inhibitor B1) is a novel specific S aureus Ser/Thr protein kinase (STK1) inhibitor with IC50 of 49 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameInh2-B1
-
NoteResearch use only, not for human use.
-
Brief DescriptionInh2-B1 (STK1 inhibitor B1) is a novel specific S aureus Ser/Thr protein kinase (STK1) inhibitor with IC50 of 49 uM.
-
DescriptionInh2-B1 (STK1 inhibitor B1) is a novel specific S aureus Ser/Thr protein kinase (STK1) inhibitor with IC50 of 49 uM, directly binds to ATP-binding catalytic domain; exhibits in vitro growth inhibition of MRSA, and in vivo protection in mice against the lethal MRSA challenge; down-regulates cell wall hydrolase genes and disrupts the biofilm formation of MRSA.
-
SynonymsSTK1 inhibitor B1
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number690216-38-7
-
Formula Weight411.45
-
Molecular FormulaC19H13N3O4S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameMethyl 5-oxo-3-(phenyl carbamoyl)-1-thioxo-4,5dihydro[1,3]thiazolo[3,4-a]quinazoline-8-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kant S, et al. Sci Rep. 2017 Jul 11;7(1):5067.
molnova catalog
related products
-
Rifaximin
Rifaximin is an oral, semi-synthetic antibiotic derived from Rifamycin SV with antibacterial activity.
-
1835F03
1835F03 is a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus.
-
JCP251
JCP251 is a selective small molecule inhibitor of S. aureus serine hydrolase FphB, effectively reduces infectivity in vivo.
